Antitumor structure–activity relationship in bis-stannoxane derivatives from pyridine dicarboxylic and benzoic acids-Reference-Cited by-同舟云学术

Antitumor structure–activity relationship in bis-stannoxane derivatives from pyridine dicarboxylic and benzoic acids

Published:2012-09 Issue: Volume:392 Page:229-235
ISSN:0020-1693
Container-title:Inorganica Chimica Acta
language:en
Short-container-title:Inorganica Chimica Acta

Author:

Valcarcel José Antonio,Razo-Hernández Rodrigo Said,Valdez-Velázquez Laura Leticia,García Manuel Villanueva,Organillo Ángel Andrés Ramos,Vázquez-Vuelvas Oscar F.,García Ruiz Miguel A.,Gómez-Sandoval Zeferino

Publisher

Elsevier BV

Subject

Materials Chemistry,Inorganic Chemistry,Physical and Theoretical Chemistry

Reference38 articles.

1. Organometallic compounds in oncology: implications of novel organotins as antitumor agents

2. Tin-based antitumour drugs

3. Study of the Anticancer Properties of Tin(IV) Carboxylate Complexes on a Panel of Human Tumor Cell Lines

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, structural characterization, and DNA binding/cleavage studies of diorganotin(IV) carboxylates and their complexes with 1,10-phenanthroline: X-ray structures of [Me8Sn4(p-FC6H4CO2)4O2], [Bu2Sn(p-NO2C6H4CO2)2.phen], and DFT studies;Journal of Molecular Structure;2024-03

2. Synthesis and structural characterization of novel di-substituted pyridine-2,6-dicarboxylic acid hydrazide oxo-quinazoline derivative and Cu(II) pincer complex;Polyhedron;2024-02

3. Synthesis and Structural Characterization of Novel Di-Substituted Pyridine-2,6-Dicarboxylic Acid Hydrazide Oxo-Quinazoline Derivative and Cu(Ii) Pincer Complex;2023

4. Synthesis and structural characterization of new ladder-like organostannoxanes derived from carboxylic acid derivatives: [C₅H₄N(p-CO₂)]₂[Bu₂Sn]₄(μ ₃-O)₂(μ ₂-OH)₂, [Ph₂CHCO₂]₄[Bu₂Sn]₄(μ ₃-O)₂, and [(p-NH₂)-C₆H₄-CO₂]₂[Bu₂Sn]₄(μ ₃-O)₂(μ ₂-OH)₂;Main Group Metal Chemistry;2022-01-01

5. In silico receptor-based drug design of X,Y-benzenesulfonamide derivatives as selective COX-2 inhibitors;Comptes Rendus Chimie;2017-02